FCGR2B and chronic inflammatory demyelinating polyradiculoneuropathy: Furthermore, results of several studies showed that FcγRIIb is upregulated on innate immune effector cells and B cells after IVIg treatment in mice [11,17,19], and this was confirmed in patients with CIDP, in whom FcγRIIb expression levels on B cells were impaired.